Physician profile
Charles Bugg
NPI 1417920620
$1,083.10
in general payments reported to CMS, 2019-2025
23 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $478 · 2021: $65.10 · 2022: $108 · 2023: $37.95 · 2024: $77.43 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $294.62 | 2020 | |
| Procept Biorobotics Corporation | $125.72 | 2024-2025 | Aquabeam System |
| Allergan, INC. | $105.75 | 2020 | |
| Abbvie INC. | $80.10 | 2019-2022 | |
| Neotract INC. | $56.40 | 2019 | |
| Astellas Pharma US INC | $52.37 | 2019 | |
| Merck Sharp & Dohme LLC | $52.05 | 2023-2024 | Keytruda, Welireg |
| Medtronic, INC. | $51.13 | 2021 | |
| Janssen Biotech, INC. | $45.56 | 2019-2025 | Erleada |
| Axonics, INC. | $26.32 | 2022-2023 | Axonics |
| Baxter Healthcare | $25.65 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.36 | 2020 | |
| Intuitive Surgical, INC. | $21.15 | 2019 | |
| Integra Lifesciences Corporation | $19.22 | 2022 | |
| Mckesson Patient Care Solutions INC. | $19.01 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.14 | 2019 | |
| Genzyme Corporation | $15.56 | 2020 | |
| Antares Pharma, INC. | $15.41 | 2020 | |
| Urogen Pharma, INC. | $12.63 | 2022 | |
| Mission Pharmacal Company | $11.67 | 2019 | |
| Endo Pharmaceuticals INC. | $11.48 | 2021 | |
| Travere Therapeutics, INC. | $3.80 | 2019-2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Bugg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.